Back to search

Biosimax Lifesciences Ltd

15398353

active
ltd
england wales
Companies House
Health Score
65 / 100

Some Concerns

25/30
Filing
0/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)
  • Negative net worth (-10)
  • Current liabilities exceed current assets (-10)

Details

Renold Building, 81 Sackville Street, Manchester, M1 3NJ
Incorporated 09/01/2024

Compliance

Last accounts

31/01/2025

micro entity

Next accounts due

31/10/2026

On track

Confirmation statement

Last: 16/07/2026

Due 30/07/2027

On track

Industry

21100
Manufacture of basic pharmaceutical products

Officers

Mr Timothy Mark Cooper

director · Since 09/01/2024

FINANCE DIRECTOR

BRITISH · ENGLAND · Age 60

Infinity Automation Limited

director · Since 09/01/2024

Mr Patrick Mciver

director · Since 09/01/2024

BUSINESS EXECUTIVE

BRITISH · UNITED KINGDOM · Age 63

Mr Adrian Paul Wallis Bsc Msc Mba C Eng Fi Mah E

director · Since 09/01/2024

CEO

BRITISH · ENGLAND · Age 68

Also on 3 other boards

Dr Theodore Andrew Willison-Parry

director · Since 09/01/2024

MEDICAL DOCTOR

BRITISH · ENGLAND · Age 35

Also on 1 other board

Timothy Mark Cooper

director · Since 09/01/2024

FINANCE DIRECTOR

BRITISH · UNITED KINGDOM · Age 58

Professor Luigi Gerard Martini Bsc Phd Mr Pharms

director · Since 26/01/2024

CHIEF EXECUTIVE OF PHTA

BRITISH · ENGLAND · Age 57

Also on 6 other boards

Timothy Mark Cooper

director · Since 09/01/2024

British · United Kingdom · Age 58

Infinity Automation Limited

corporate director · Since 09/01/2024

Reg: SC359447

Patrick Mciver

director · Since 09/01/2024

British · United Kingdom · Age 63

Adrian Paul Wallis

director · Since 09/01/2024

British · England · Age 68

Theodore Andrew Willison-Parry

director · Since 09/01/2024

British · England · Age 35

Luigi Gerard Martini

director · Since 26/01/2024

British · England · Age 57

Persons with Significant Control

Former PSCs

Mr Patrick Mciver

Ceased 15/04/2024

Change History

statusactive
2026-07-29

Active

typeltd
2026-07-29

Private Limited Company

address line1Renold Building
2026-07-29

RENOLD BUILDING

post townManchester
2026-07-29

MANCHESTER

officer appointedCOOPER, Timothy Mark
2026-07-29
officer appointedMARTINI, Luigi Gerard, Professor
2026-07-29
officer appointedMCIVER, Patrick
2026-07-29
officer appointedWALLIS, Adrian Paul
2026-07-29
officer appointedWILLISON-PARRY, Theodore Andrew, Dr
2026-07-29
officer appointedINFINITY AUTOMATION LIMITED
2026-07-29

CompanyRankvs 790+ SIC 21100 peers
33

Financial strength18th percentile among SIC peers · 5/25
Employees26th percentile among SIC peers · 4/15
LiquidityCurrent ratio 0.62× · 6/20
Longevity3 years trading (max 15) · 3/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength5/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees4/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity6/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity3/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/01/2025

Net Worth

-£1k

Balance sheet strength

Cash

Cash in the bank

Net Current Assets

-£959

Working capital

Current Assets

£2k

Current Liabilities

£3k

0avg. employees

Balance Sheet

Assets less current liabilities-£959
Prepared with BTCSoftware AP Solution 2025 12.1.01

EstimatesDerived

YearCurrent Ratio
20250.62

Derived from filed accounts. Not audited figures.